October 2010
Heart;Oct2010 Supplement, pA58
Academic Journal
An abstract of the article "The Protection Effects of Trimetazidine on Rats Myocardial Infarction" by Yanting Luo and colleagues is presented.


Related Articles

  • Drug Therapy.  // Current Medical Literature: Cardiology;2008, Vol. 27 Issue 2, p56 

    The article discusses various research being done on drug therapy. They include the incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome, with reference to a study by P. M. Ho et al in the "Journal of the American Medical...

  • ISCHEMIC HEART DISEASE.  // Current Medical Literature: Cardiology;2004, Vol. 23 Issue 4, p85 

    This section presents abstracts of medical research. They include "Three-Year Outcome After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease," "Bleeding Events with Abciximab in Acute Coronary Syndromes Without Early Revascularization: An Analysis of GUSTO...

  • Full Coverage for Preventive Medications after Myocardial Infarction. Choudhry, Niteesh K.; Avorn, Jerry; Glynn, Robert J.; Antman, Elliott M.; Schneeweiss, Sebastian; Toscano, Michele; Reisman, Lonny; Fernandes, Joaquim; Spettell, Claire; Lee, Joy L.; Levin, Raisa; Brennan, Troyen; Shrank, William H. // New England Journal of Medicine;12/1/2011, Vol. 365 Issue 22, p2088 

    Background: Adherence to medications that are prescribed after myocardial infarction is poor. Eliminating out-of-pocket costs may increase adherence and improve outcomes. Methods: We enrolled patients discharged after myocardial infarction and randomly assigned their insurance-plan sponsors to...

  • Spotlight on Enoxaparin in ST-Segment Elevation Myocardial Infarction. Carter, Natalie J.; McCormack, Paul L.; Plosker, Greg L. // BioDrugs;2008, Vol. 22 Issue 5, p343 

    Enoxaparin (enoxaparin sodium; Lovenox) is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percutaneous coronary intervention. It binds to and...

  • The Role of Clopidogrel in Revascularized and Nonrevascularized Patients with Acute Coronary Syndromes. Collins, J. Stewart; Gurm, Hitinder S. // American Journal of Cardiovascular Drugs;2007, Vol. 7 Issue 3, p159 

    Despite many recent advancements in the treatment of coronary heart disease, it continues to be an important source of patient morbidity and mortality as well as a significant source of healthcare-related expenditures. Clopidogrel has become an integral part of the management of acute coronary...

  • Increased statin prescribing could reduce MI mortality.  // PharmacoEconomics & Outcomes News;7/1/2006, Issue 506, p8 

    The article discusses research being done on the use of statin in myocardial infarction (MI). It references a study by P. C. Austin in the May 2006 issue of the "American Heart Journal." Several MI survivors discharged from hospitals in Ontario between April 1999 and March 2001 were included in...

  • Intracoronary vs Intravenous Abciximab for ST elevation MI. Boyle, Andrew J. // Clinical Cardiology Alert;Aug2008, Vol. 27 Issue 8, p63 

    The article discusses a study which compared intracoronary abciximab and intravenous abciximab for ST elevation myocardial infarction (MI). It was found that intracoronary (IC) abciximab is better than intravenous (IV) abciximab with reference to reducing infarct size. Comments on how the study...

  • Can daily aspirin stop heart attacks? Tanday, Sanjay // GP: General Practitioner;9/5/2008, p17 

    The article reports on the efficacy of aspirin in preventing heart attacks among middle-aged men and women, according to a study in Great Britain. According to the study, men from the age of 48 and women aged 58 and over were at risk of developing chronic heart disease (CHD). It is said that the...

  • Metoprolol overdose.  // Reactions Weekly;6/16/2007, Issue 1156, p17 

    The article presents a case report of myocardial infarction in a patient with coronary artery disease. After ingesting an overdose of metoprolol in a suicide attempt, a 56-year-old woman, with a history of coronary artery disease, had an acute myocardial infarction and junctional dysrhythmia....


Read the Article


Sign out of this library

Other Topics